Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Avai Bio (AVAI) Operating Expenses (2018 - 2025)

Avai Bio's Operating Expenses history spans 6 years, with the latest figure at $303432.0 for Q1 2024.

  • On a quarterly basis, Operating Expenses rose 142.86% to $303432.0 in Q1 2024 year-over-year; TTM through Mar 2024 was $2.1 million, a 555.21% increase, with the full-year FY2025 number at $1.5 million, down 27.6% from a year prior.
  • Operating Expenses hit $303432.0 in Q1 2024 for Avai Bio, down from $1.0 million in the prior quarter.
  • Over the last five years, Operating Expenses for AVAI hit a ceiling of $1.0 million in Q4 2023 and a floor of $35950.0 in Q2 2020.
  • Historically, Operating Expenses has averaged $235093.7 across 4 years, with a median of $107646.5 in 2022.
  • Biggest five-year swings in Operating Expenses: grew 19.44% in 2020 and later skyrocketed 1939.34% in 2023.
  • Tracing AVAI's Operating Expenses over 4 years: stood at $70960.0 in 2020, then decreased by 29.94% to $49717.0 in 2022, then skyrocketed by 1939.34% to $1.0 million in 2023, then tumbled by 70.07% to $303432.0 in 2024.
  • Business Quant data shows Operating Expenses for AVAI at $303432.0 in Q1 2024, $1.0 million in Q4 2023, and $388328.0 in Q3 2023.